###begin article-title 0
###xml 47 69 47 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum </italic>
###xml 47 68 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Host erythrocyte polymorphisms and exposure to Plasmodium falciparum in Papua New Guinea
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 89 110 89 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum</italic>
###xml 27 32 <span type="species:ncbi:9606">human</span>
###xml 89 110 <span type="species:ncbi:5833">Plasmodium falciparum</span>
The protection afforded by human erythrocyte polymorphisms against the malaria parasite, Plasmodium falciparum, has been proposed to be due to reduced ability of the parasite to invade or develop in erythrocytes. If this were the case, variable levels of parasitaemia and rates of seroconversion to infected-erythrocyte variant surface antigens (VSA) should be seen in different host genotypes.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 25 39 25 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 266 267 262 263 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 25 38 <span type="species:ncbi:5833">P. falciparum</span>
###xml 127 135 <span type="species:ncbi:9606">children</span>
To test this hypothesis, P. falciparum parasitaemia and anti-VSA antibody levels were measured in a cohort of 555 asymptomatic children from an area of intense malaria transmission in Papua New Guinea. Linear mixed models were used to investigate the effect of alpha+-thalassaemia, complement receptor-1 and south-east Asian ovalocytosis, as well as glucose-6-phosphate dehydrogenase deficiency and ABO blood group on parasitaemia and age-specific seroconversion to VSA.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
No host polymorphism showed a significant association with both parasite prevalence/density and age-specific seroconversion to VSA.
###end p 7
###begin title 8
Conclusion
###end title 8
###begin p 9
###xml 104 118 104 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 104 117 <span type="species:ncbi:5833">P. falciparum</span>
Host erythrocyte polymorphisms commonly found in Papua New Guinea do not effect exposure to blood stage P. falciparum infection. This contrasts with data for sickle cell trait and highlights that the above-mentioned polymorphisms may confer protection against malaria via distinct mechanisms.
###end p 9
###begin title 10
Background
###end title 10
###begin p 11
###xml 160 161 156 157 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 511 512 507 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 513 515 509 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 705 714 701 710 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro </italic>
###xml 760 782 756 778 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum </italic>
###xml 836 838 832 834 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 943 956 939 952 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum</italic>
###xml 1034 1036 1030 1032 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 1037 1039 1033 1035 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 1082 1083 1074 1075 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1166 1167 1158 1159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 1168 1170 1160 1162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 1171 1173 1163 1165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 1174 1176 1166 1168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 760 781 <span type="species:ncbi:5833">Plasmodium falciparum</span>
###xml 943 956 <span type="species:ncbi:5833">P. falciparum</span>
Human erythrocyte polymorphisms have long been thought to play a role in resistance to malaria. High frequencies of host erythrocyte polymorphisms such as alpha+-thalassaemia, haemoglobin (Hb) S, Hb C, Hb E, complement receptor-1 (CR1) deficiency, glucose-6-phosphate dehydrogenase (G6PD) deficiency and south-east Asian ovalocytosis (SAO) are found in malaria endemic areas. Case-control studies have demonstrated that these polymorphisms reduce the risk of severe falciparum malaria rather than mild malaria [1-22]. Experimentally, research has focused on examining the interactions between the parasite and the erythrocyte to try to understand possible mechanisms of protection of these polymorphisms. In vitro experiments have suggested reduced ability of Plasmodium falciparum to invade or sustain growth in abnormal erythrocytes [23]. Enhanced clearance of infected erythrocytes by phagocytosis, and increased enhanced susceptibility of P. falciparum-infected abnormal erythrocytes to oxidative stress, have also been proposed [24-28]. It has also been hypothesized that alpha+-thalassaemia, CR1 deficiency and blood group O may protect via reduced rosetting [5,21,29-32], the phenomenon whereby non-parasitized erythrocytes bind to parasitized erythrocytes.
###end p 11
###begin p 12
###xml 170 172 170 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 173 175 173 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 176 178 176 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 179 181 179 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 253 267 253 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 318 320 318 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 822 823 818 819 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 838 840 834 836 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 841 843 837 839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 851 853 847 849 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 854 856 850 852 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 865 867 861 863 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 868 870 864 866 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 1062 1063 1058 1059 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 1064 1066 1060 1062 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 1067 1069 1063 1065 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 1070 1072 1066 1068 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B65">65</xref>
###xml 253 266 <span type="species:ncbi:5833">P. falciparum</span>
It is well documented that individuals with sickle cell trait (HbAS) have lower parasite densities compared to HbAA individuals in asymptomatic, mild and severe malaria [18-20,33-44]. This, together with the observation that the time to reappearance of P. falciparum is lower in HbAS individuals after drug treatment [39], provides compelling evidence for a direct interaction of the parasite with the HbS containing erythrocytes or of improved immunity controlling the level of parasitaemia in those with sickle cell trait. However, data on other erythrocyte polymorphisms is less clear cut. Clinical studies have rarely demonstrated differences in parasite density among genotypes in symptomatic malaria. Epidemiological studies in asymptomatic individuals are inconsistent. Cross-sectional studies have shown that alpha+-thalassaemia [45,46], SAO [47,48], G6PD [49-53] and ABO polymorphisms (no studies have examined CR1) have reduced parasite rates/densities while other studies provide no evidence of an effect of these polymorphisms on parasite densities [4,11,54-65]. Data from a single time point may not accurately represent exposure to infection and therefore results of these studies are hard to interpret.
###end p 12
###begin p 13
###xml 254 267 254 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum</italic>
###xml 335 349 335 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 467 469 467 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B66">66</xref>
###xml 548 561 548 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum</italic>
###xml 588 590 588 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B67">67</xref>
###xml 736 738 736 738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B68">68</xref>
###xml 870 872 870 872 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B69">69</xref>
###xml 896 910 896 910 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 254 267 <span type="species:ncbi:5833">P. falciparum</span>
###xml 335 348 <span type="species:ncbi:5833">P. falciparum</span>
###xml 548 561 <span type="species:ncbi:5833">P. falciparum</span>
###xml 896 909 <span type="species:ncbi:5833">P. falciparum</span>
###xml 910 918 <span type="species:ncbi:9606">children</span>
###xml 965 973 <span type="species:ncbi:9606">children</span>
There are two possible ways to measure exposure to malaria blood stage infection: 1) by comparing parasite prevalence/density and, 2) by comparing age-specific antibody seroconversion to major blood stage antigens among host genotypes. Seroconversion to P. falciparum-infected erythrocyte variant surface antigens (VSA), which include P. falciparum erythrocyte membrane protein-1 (PfEMP-1) and rifins, has been shown to be dependent on the intensity of transmission [66]. Antibody levels in endemic areas reflect the level of IgG seroconversion to P. falciparum-infected erythrocyte VSA [67]. Furthermore, a study in Tanzania showed that insecticide-treated bednets limited the repertoire of recognized VSA and reduced antibody levels [68]. Seroconversion can also be considered as a marker for the level of cumulative exposure to the parasite as it increases with age [69]. The more exposure to P. falciparum children receive in malaria-endemic areas, the younger children will seroconvert to VSA.
###end p 13
###begin p 14
###xml 319 320 315 316 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 3 8 <span type="species:ncbi:9606">human</span>
###xml 411 419 <span type="species:ncbi:9606">children</span>
###xml 531 539 <span type="species:ncbi:9606">children</span>
If human erythrocyte polymorphisms were to hamper invasion and/or growth of the parasite or enhance the antibody-dependent control of malarial infection, this should manifest as differences in both mean parasite densities and patterns of age-specific seroconversion to VSA. The frequency of the host polymorphisms alpha+-thalassaemia, CR1, ABO blood group, SAO and G6PD deficiency were determined in a group of children from Papua New Guinea (PNG). Parasitological criteria and levels of anti-VSA antibodies were measured in these children in two consecutive surveys, one year apart. The relationship between these genetic polymorphisms, parasite prevalence/density and age-specific antibody seroconversion to VSA was investigated in a malaria endemic region of PNG.
###end p 14
###begin title 15
Methods
###end title 15
###begin title 16
Study design and data collection
###end title 16
###begin p 17
###xml 75 77 75 77 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 276 278 276 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B70">70</xref>
###xml 557 561 557 559 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
###xml 673 677 671 673 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
###xml 151 159 <span type="species:ncbi:9606">children</span>
###xml 352 360 <span type="species:ncbi:9606">children</span>
###xml 782 787 <span type="species:ncbi:9606">human</span>
Details of study design and data collection have been reported previously [54]. Briefly, a serial cross-sectional survey was conducted in asymptomatic children living in villages of the Amele region, Madang Province, PNG, where intense year-round malaria transmission occurs [70]. The study took place from November to December of 1999 and 2000 in 566 children aged 1-17 years. A serial study design would ensure that any associations observed with host genotype would be less likely to have occurred by chance. Blood samples were collected using Vacutainer(R) tubes (Becton Dickinson, UK) and EDTA as anti-coagulant. A small aliquot of whole blood was blotted onto Isocode(R) Stix (Schleicher & Schuell GmbH, Dassel, Germany) following the manufacturer's instructions, for further human genetic analyses. The remaining blood was centrifuged and separated into plasma (stored at -80degreesC), buffy coat and erythrocyte pellet, both stored in guanidine hydrochloride at 4degreesC. 555 paired samples were available for antibody determination.
###end p 17
###begin title 18
DNA polymorphism analysis
###end title 18
###begin p 19
###xml 5 6 1 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 74 76 70 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 130 132 126 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B71">71</xref>
###xml 162 166 158 160 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
###xml 492 496 486 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hind</italic>
###xml 544 545 538 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 546 548 540 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B72">72</xref>
###xml 140 145 <span type="species:ncbi:9606">human</span>
alpha+-Thalassaemia genotype was determined by polymerase chain reaction [54]. SAO genotyping was conducted as described earlier [71] using human DNA from Isocode(R) Stix. G6PD deficiency was evaluated qualitatively (Sigma Diagnostics visual colourimetric assay) and ABO blood groups were determined using anti-A and anti-B antibodies from a kit (BIOSCOT, Edinburgh, Scotland). CR1 genotype was determined by polymerase chain reaction and restriction fragment length polymorphism digest with HindIII as previously described with modifications [5,72].
###end p 19
###begin title 20
Parasites
###end title 20
###begin p 21
###xml 0 14 0 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 176 178 176 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B73">73</xref>
###xml 567 576 566 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 615 617 614 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B74">74</xref>
###xml 639 641 638 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B75">75</xref>
###xml 779 780 778 779 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 786 787 785 786 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 798 799 797 798 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1016 1018 1015 1017 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B67">67</xref>
###xml 0 13 <span type="species:ncbi:5833">P. falciparum</span>
###xml 53 58 <span type="species:ncbi:9606">child</span>
P. falciparum isolate PNG/M 12, was collected from a child presenting with acute symptomatic malaria at an aid post in Madang, during a longitudinal cohort study from 1990/91 [73]. Erythrocytes were washed three times after buffy coat depletion in RPMI 1640 media buffered with 25 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) and supplemented with 25 mM sodium bicarbonate, 2 mM L-glutamine, 300 mM hypoxanthine and 10 mug/ml gentamicin (Gibco, UK) (RPMI-HEPES), and cryopreserved in liquid nitrogen for adaptation in Oxford. Parasites were cultured in vitro using the method of Trager and Jensen [74] with modifications [75]. Cells were grown in RPMI/HEPES supplemented with 10% AB serum (from donors residing in a non-malarious area), in an atmosphere of 5% CO2, 2% O2, and 93% N2, sub-cultured into O positive erythrocytes (Oxford Blood Transfusion Service, UK) and stabilates frozen down. Adaptation and maintenance of PfEMP-1 expressing lines were made following a previously published method [67].
###end p 21
###begin title 22
Surface Immunofluorescence Assay (SIFA)
###end title 22
###begin p 23
###xml 107 109 107 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B67">67</xref>
###xml 177 181 177 179 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
###xml 226 228 224 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B76">76</xref>
###xml 1372 1374 1349 1351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B67">67</xref>
###xml 1510 1512 1487 1489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B67">67</xref>
###xml 268 273 <span type="species:ncbi:9606">human</span>
###xml 562 568 <span type="species:ncbi:9913">Bovine</span>
###xml 620 626 <span type="species:ncbi:9986">rabbit</span>
###xml 632 637 <span type="species:ncbi:9606">human</span>
###xml 733 738 <span type="species:ncbi:9823">swine</span>
###xml 744 750 <span type="species:ncbi:9986">rabbit</span>
###xml 1190 1195 <span type="species:ncbi:9606">human</span>
###xml 1420 1425 <span type="species:ncbi:9606">human</span>
Detection of antibodies bound to the surface of infected erythrocytes (IE) have previously been described [67]. Briefly, trophozoites were synchronized and enriched by Plasmagel(R) (Laboratoire Roger Bellon, France) flotation[76]. After washing 2x in RPMI and 1x with human tonicity phosphate-buffered saline (HTPBS)/1% BSA (Sigma, UK), trophozoite-IE were adjusted to 10 - 15% parasitaemia. Fifty mul of 1/50 dilution of plasma was added to 5 mul packed cell volume of IE and incubated for 30 mins at RT. All washes between each step were done 3x with HTPBS/1% Bovine serum albumin (BSA). The next antibody layer was a rabbit anti-human IgG (Dako, UK) (1/100 dilution). The final antibody layer was a 1/100 dilution of FITC-coupled swine anti-rabbit IgG (Dako, UK) containing 50 mug/ml ethidium bromide. Cells were fixed for 1 h with 0.5% paraformaldehyde diluted in HTPBS/1% BSA, then washed 1x and resuspended with HTPBS. Samples were read on a FACSCaliburtrade mark flow cytometer (Becton Dickinson, UK): 1000 IE were counted using the program CELLQUESTtrade mark 3.3 (Becton Dickinson, UK) for Macintosh. A hyper immune plasma (HIP) pool from 10 adult residents from Madang and normal human serum (NHS) from three non malaria-exposed Europeans (Oxford Blood Transfusion Service, UK) were used as positive and negative controls, respectively, as previously described [67]. The percentage of IE staining positive for human plasma was calculated relative to the response to HIP and NHS as described earlier [67].
###end p 23
###begin title 24
Statistical analysis
###end title 24
###begin p 25
###xml 151 165 151 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 344 346 342 344 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 880 894 878 892 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 925 939 923 937 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 1038 1052 1036 1050 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 1110 1111 1104 1105 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1600 1602 1594 1596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B77">77</xref>
###xml 1662 1663 1652 1653 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1687 1688 1677 1678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 1972 1974 1962 1964 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B78">78</xref>
###xml 151 164 <span type="species:ncbi:5833">P. falciparum</span>
###xml 880 893 <span type="species:ncbi:5833">P. falciparum</span>
###xml 925 938 <span type="species:ncbi:5833">P. falciparum</span>
###xml 1038 1051 <span type="species:ncbi:5833">P. falciparum</span>
Due to the repeated measures study design, appropriate statistical tests were chosen to analyze paired data. The association of host polymorphisms and P. falciparum presence in no surveys, one survey and two surveys was assessed by ordinal regression with adjustments for age. Differences in frequency of positive slides were assessed using chi2 tests for each study year. Linear mixed models were used to examine the variation of parasite density among host genotypes with adjustments for age. Linear mixed models were also used to investigate the effect of age, parasite density and genotype on antibody levels: the two values were treated as a repeated measure with a heterogeneous compound symmetry covariance structure. Since the antibody levels showed considerable heteroscedasticity, they were transformed before analysis, using the transformation log(antibody + 2.5). The P. falciparum counts were transformed by log(P. falciparum + 1) to reduce skewness while leaving the zero values unchanged. The models examined the effect of P. falciparum (logarithm of density), age (continuous), and either alpha+-thalassaemia genotype, CR1 genotype, ABO blood group (four categories [A, B, AB, O] and two categories [O and non-O]), SAO genotype or G6PD phenotype (three categories [normal, intermediate, deficient] and two categories [normal, abnormal]). Interactions between host erythrocyte polymorphisms were also examined but some subgroups obtained were too small for reliable analysis. An interaction between sex and G6PD deficiency was also examined as G6PD deficiency is an X-linked disorder [77]. CR1 expression has been shown to be associated with alpha+-thalassaemia genotype [5], therefore adjustments were made for the respective polymorphism in ordinal regression and mixed linear analysis. Addition of each polymorphism in each analysis did not alter the final result so no adjustments were made in the final models. The models were developed using R 1.8.1 [78] and SPSS (version 12.0) and variables with p-values < .05 were considered significant.
###end p 25
###begin p 26
Informed consent was obtained from subjects and their parents or guardians. The project received ethical approval from the PNG Medical Research Advisory Committee and Institutional Review Board of the New York University School of Medicine.
###end p 26
###begin title 27
Results
###end title 27
###begin title 28
Characteristics of study cohort
###end title 28
###begin p 29
###xml 263 277 261 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 332 348 330 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium vivax</italic>
###xml 396 410 394 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 414 422 412 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. vivax</italic>
###xml 459 473 457 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 569 574 566 568 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#946; </italic>
###xml 609 611 603 605 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 61 69 <span type="species:ncbi:9606">children</span>
###xml 263 276 <span type="species:ncbi:5833">P. falciparum</span>
###xml 332 348 <span type="species:ncbi:5855">Plasmodium vivax</span>
###xml 396 409 <span type="species:ncbi:5833">P. falciparum</span>
###xml 414 422 <span type="species:ncbi:5855">P. vivax</span>
###xml 459 472 <span type="species:ncbi:5833">P. falciparum</span>
1,100 blood samples and thick smears were collected from 555 children aged 1-17 years (mean age 9.68 +/- 0.18) in the Amele region, Madang Province, PNG at two surveys in November-December of 1999 and 2000. Thirty-eight percent of samples were slide-positive for P. falciparum in both years of the study and 24.7% were positive for Plasmodium vivax. Only 57 samples (5.2%) were positive for both P. falciparum and P. vivax. Geometric mean parasite density of P. falciparum was 680 parasites/mul (95% CI 567-814) and parasite density was negatively correlated with age (beta = -0.08, standard error [SE] 0.02, P = .002).
###end p 29
###begin p 30
###xml 6 7 6 7 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 100 101 96 97 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
Table 1 details the frequency of polymorphisms investigated in this study. High frequencies of alpha+-thalassaemia were found in this population (92.9%) with a predominance of the 4.2 deletion allele (frequency = 0.71). The CR1 L allele was also predominant with a prevalence of 94.6%, whereas the host erythrocyte polymorphisms SAO and G6PD were relatively uncommon in this population (< 10%).
###end p 30
###begin p 31
###xml 51 59 <span type="species:ncbi:9606">children</span>
Host polymorphism and parasitological data for 555 children from the Amele region, Papua New Guinea
###end p 31
###begin p 32
###xml 0 2 0 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a </italic>
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>a </italic></sup>
###xml 2 10 2 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Missing </italic>
a Missing data: 1999, n = 1; 2000, n = 21.
###end p 32
###begin p 33
###xml 0 2 0 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b </italic>
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>b </italic></sup>
b Differences in frequency of positive slides were assessed using ordinal regression with adjustments for age.
###end p 33
###begin p 34
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">c </sup>
c Abbreviations: CR1, Complement receptor 1; SAO, Southeast Asian Ovalocytosis; G6PD, Glucose-6-phosphate dehydrogenase deficiency. With the exception of SAO, these variables contain missing values.
###end p 34
###begin title 35
###xml 23 37 23 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 23 36 <span type="species:ncbi:5833">P. falciparum</span>
Host polymorphisms and P. falciparum prevalence and density
###end title 35
###begin p 36
###xml 6 7 6 7 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 41 55 41 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 172 173 168 169 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 188 190 184 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 202 204 198 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 231 233 227 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 244 258 240 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 370 371 362 363 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 386 388 378 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 401 403 393 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 430 432 422 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 616 618 608 610 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 632 646 624 638 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 750 764 742 756 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 808 810 800 802 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 907 909 899 901 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1037 1051 1027 1041 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 1145 1147 1135 1137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1255 1268 1245 1258 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum</italic>
###xml 1324 1337 1313 1326 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum</italic>
###xml 1360 1362 1348 1350 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1389 1402 1377 1390 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum</italic>
###xml 1424 1426 1411 1413 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 31 36 <span type="species:ncbi:9606">child</span>
###xml 41 54 <span type="species:ncbi:5833">P. falciparum</span>
###xml 244 257 <span type="species:ncbi:5833">P. falciparum</span>
###xml 494 502 <span type="species:ncbi:9606">Children</span>
###xml 632 645 <span type="species:ncbi:5833">P. falciparum</span>
###xml 750 763 <span type="species:ncbi:5833">P. falciparum</span>
###xml 980 988 <span type="species:ncbi:9606">Children</span>
###xml 1037 1050 <span type="species:ncbi:5833">P. falciparum</span>
###xml 1255 1268 <span type="species:ncbi:5833">P. falciparum</span>
###xml 1324 1337 <span type="species:ncbi:5833">P. falciparum</span>
###xml 1389 1402 <span type="species:ncbi:5833">P. falciparum</span>
Table 1 also details whether a child was P. falciparum positive for one survey, two surveys or no surveys, according to host polymorphism. There was no association of alpha+-thalassaemia (P > .7), SAO (P = .29) or G6PD deficiency (P > .3) with P. falciparum prevalence either at both surveys, after adjustments for age. There was also no significant association of alpha+-thalassaemia (P = .78), SAO (P = .66) or G6PD deficiency (P = .64) with mean parasite density, after adjustments for age. Children who were blood group B were less likely to be positive at both surveys compared to those who were blood group O (P = .005). When P. falciparum prevalence was analysed separately for each year, blood group B had a significantly lower prevalence of P. falciparum (27.8%) compared to O (43.3%) in 2000 only (P = .02). There was no significant difference in mean parasite densities between ABO blood groups (P </= .4) as assessed by a mixed linear model, with adjustments for age. Children with the CR1 HL genotype were more likely to be P. falciparum positive for both surveys compared to HH individuals but this was of borderline significance (P = .07). There was also weak evidence of CR1 HH genotype having lower geometric mean parasite densities (322 P. falciparum/mul, 95%CI 129-807) compared to those who were HL (786 P. falciparum/mul, 95% CI 584-1058, P = .07) or LL genotype (688 P. falciparum/mul, 95% CI 540-876, P = .12).
###end p 36
###begin title 37
Host polymorphisms and age-specific seroconversion to VSA
###end title 37
###begin p 38
###xml 146 151 146 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#946; </italic>
###xml 169 171 166 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 197 202 194 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#946; </italic>
###xml 220 222 214 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 519 521 513 515 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 536 538 528 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 563 565 555 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 680 682 672 674 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 763 765 755 757 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 801 802 789 790 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 871 872 859 860 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 915 916 899 900 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1013 1015 997 999 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1167 1168 1147 1148 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1183 1185 1163 1165 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 649 657 <span type="species:ncbi:9606">children</span>
###xml 875 883 <span type="species:ncbi:9606">Children</span>
###xml 984 992 <span type="species:ncbi:9606">children</span>
###xml 1099 1107 <span type="species:ncbi:9606">children</span>
A multivariate linear mixed model was used to examine the effect of age and parasitaemia on antibody levels in samples from the cohort. Both age (beta = 0.16, SE 0.009, P < .001) and parasitaemia (beta = 0.03, SE 0.007, P < .001) were found to positively influence antibody levels. This model was then applied to each of the five host erythrocyte polymorphisms investigated in this study. There was no significant difference in the age-dependent acquisition of VSA-specific antibodies with respect to ABO blood groups (P >/= .39), SAO (P = .39), or CR1 genotype (P = .99). There was also no significant difference in age-dependent seroconversion in children with G6PD deficiency (P > .2), nor was there evidence of an interaction between G6PD deficiency and sex (P = .16). There was an effect of alpha+-thalassaemia on age-dependent anti-VSA antibody acquisition (Figure 1). Children who were heterozygous for alpha+-thalassaemia had a slower rate of antibody acquisition compared to children of normal genotype (P = .02). There was no significant difference in rate of antibody acquisition between children of normal genotype and those that were homozygous for alpha+-thalassaemia (P = .14).
###end p 38
###begin p 39
###xml 31 44 31 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum</italic>
###xml 109 110 105 106 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 0 132 0 128 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Age-specific seroconversion to <italic>P. falciparum</italic>-infected erythrocyte variant surface antigens according to &#945;<sup>+</sup>-thalassaemia genotype</bold>
###xml 326 340 322 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 391 392 383 384 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 522 523 510 511 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 543 545 531 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 31 44 <span type="species:ncbi:5833">P. falciparum</span>
###xml 326 339 <span type="species:ncbi:5833">P. falciparum</span>
###xml 459 467 <span type="species:ncbi:9606">children</span>
###xml 491 499 <span type="species:ncbi:9606">children</span>
Age-specific seroconversion to P. falciparum-infected erythrocyte variant surface antigens according to alpha+-thalassaemia genotype. Antibody levels are expressed as the percentage relative response to a hyper-immune plasma control (HIP). Data represent the predicted antibody levels from a mixed linear model including age, P. falciparum parasitaemia (with parasitaemia set to 0) and alpha+-thalassaemia genotype. There was statistical significance between children of normal genotype and children heterozygous for alpha+-thalassaemia only (P = 0.02).
###end p 39
###begin title 40
Discussion
###end title 40
###begin p 41
###xml 145 147 145 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B70">70</xref>
###xml 394 396 394 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B66">66</xref>
###xml 583 585 583 585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B79">79</xref>
This study investigated age-specific antibody seroconversion in Amele villages on the north coast of PNG, where malaria transmission is intense [70]. The sample size of the study was sufficiently large to allow us to look for interactions among the most common polymorphisms. Age was positively correlated with seroconversion to VSA, reflecting the association of age with exposure to malaria [66]. Parasitaemia was also positively correlated with VSA antibody levels. This result is similar to what has previously been shown in asymptomatic African populations to heterologous VSA [79]. It is therefore essential to make appropriate adjustments for age and parasitaemia when examining the association of host erythrocyte polymorphisms with age-specific antibody seroconversion.
###end p 41
###begin p 42
###xml 78 79 74 75 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 131 132 127 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 326 328 322 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B80">80</xref>
###xml 488 501 484 497 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum</italic>
###xml 807 821 803 817 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 842 843 834 835 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 954 955 946 947 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 956 958 948 950 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 959 961 951 953 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B60">60</xref>
###xml 962 964 954 956 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B62">62</xref>
###xml 1121 1122 1109 1110 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1250 1252 1238 1240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B80">80</xref>
###xml 1290 1291 1274 1275 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1454 1455 1434 1435 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1511 1512 1491 1492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 1513 1514 1493 1494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 18 26 <span type="species:ncbi:9606">children</span>
###xml 141 149 <span type="species:ncbi:9606">children</span>
###xml 202 210 <span type="species:ncbi:9606">children</span>
###xml 488 501 <span type="species:ncbi:5833">P. falciparum</span>
###xml 608 616 <span type="species:ncbi:9606">children</span>
###xml 807 820 <span type="species:ncbi:5833">P. falciparum</span>
###xml 913 921 <span type="species:ncbi:9606">children</span>
###xml 994 1002 <span type="species:ncbi:9606">children</span>
###xml 1060 1068 <span type="species:ncbi:9606">children</span>
###xml 1221 1229 <span type="species:ncbi:9606">children</span>
###xml 1482 1490 <span type="species:ncbi:9606">children</span>
Papua New Guinean children who are homozygous, but not heterozygous, for alpha+-thalassaemia are protected against severe malaria [1]. These children have significantly smaller erythrocytes compared to children of normal genotype, whereas erythrocyte parameters in heterozygotes are indistinguishable from normal individuals [80]. If there is a reduced physical interaction (i.e reduced invasion/growth, rosetting) or enhanced immune-mediated response between microcytic erythrocytes and P. falciparum, then a difference in parasite prevalence/density and seroconversion would be expected between homozygous children and those of normal genotype. This study showed there was no significant difference in age-specific seroconversion among these genotypes. Furthermore, there was no significant difference in P. falciparum density between alpha+-thalassaemia genotypes which is in concordance with other studies in children with asymptomatic parasitaemia [4,11,60-62]. There was some evidence of children of normal genotype having increased exposure compared to children who were heterozygous, but not homozygous, for alpha+-thalassaemia. This was surprising given that erythrocyte indices for heterozygotes are similar to children of normal genotype [80]. There is strong evidence that alpha+-thalassaemia confers particular protection against severe malarial anaemia. This must be independent of parasite density which has shown to be similar among alpha+-thalassaemia genotypes in children with acute malaria [1-4].
###end p 42
###begin p 43
###xml 156 170 156 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 308 310 308 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B81">81</xref>
###xml 603 617 603 617 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 793 807 793 807 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 888 902 888 902 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 156 169 <span type="species:ncbi:5833">P. falciparum</span>
###xml 541 549 <span type="species:ncbi:9606">children</span>
###xml 603 616 <span type="species:ncbi:5833">P. falciparum</span>
###xml 654 662 <span type="species:ncbi:9606">children</span>
###xml 771 779 <span type="species:ncbi:9606">children</span>
###xml 793 806 <span type="species:ncbi:5833">P. falciparum</span>
###xml 888 901 <span type="species:ncbi:5833">P. falciparum</span>
CR1 deficiency and blood group O are thought to protect against malaria by decreased rosetting. A positive correlation has been shown between rosetting and P. falciparum parasitaemia and it has been proposed that rosetting may enhance parasite survival by facilitating invasion and promoting immune evasion [81]. Polymorphisms associated with increased rosetting such as the CR1 H allele and AB blood antigens should lead to increased parasitaemia by this proposed mechanism. Contrary to this expectation, this study showed weak evidence of children with high levels of CR1 expression (HH) having lower P. falciparum prevalence and densities compared to children with lower CR1 expression (HL or LL genotype). This result could have occurred by chance given that only 15 children with HH were P. falciparum positive during the study. There was also evidence of blood group B having lower P. falciparum prevalence in the 2000 survey, but there was no significant difference in parasite densities among ABO blood groups. Neither ABO blood group and CR1 genotype had no effect on age-dependent seroconversion to anti-VSA antibodies, indicating that differences in parasitological data in these groups must have been due to chance. This study would support the hypothesis that ABO blood group and CR1 deficiency associated with the L allele protect against malaria by reduced rosetting and associated pathology rather than parasite density.
###end p 43
###begin p 44
###xml 103 117 103 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 365 367 365 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 618 620 618 620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 103 116 <span type="species:ncbi:5833">P. falciparum</span>
There was no significant difference in geometric mean parasite densities or rates of seroconversion to P. falciparum VSA with respect to G6PD and SAO genotypes. These data conflict with several studies that have proposed that innate resistance to malaria involved the inability for the malaria parasite to grow in and/or invade G6PD deficient and SAO erythrocytes [23]. There was also no evidence of an interaction between G6PD deficiency and sex with respect to anti-VSA seroconversion. A recent case-control study demonstrated that males, but not females, with G6PD deficiency were protected against severe malaria [12], but there was no significant difference in parasite density. Results presented here concur with this latter observation.
###end p 44
###begin title 45
Conclusion
###end title 45
###begin p 46
###xml 947 949 947 949 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 950 952 950 952 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 953 955 953 955 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 956 958 956 958 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 959 961 959 961 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 962 964 962 964 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B82">82</xref>
###xml 965 967 965 967 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B83">83</xref>
###xml 1071 1073 1071 1073 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B83">83</xref>
###xml 1330 1344 1330 1344 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 721 729 <span type="species:ncbi:9606">children</span>
###xml 1330 1343 <span type="species:ncbi:5833">P. falciparum</span>
Data presented here highlight the importance of measuring malaria exposure at two time points to investigate the interactions of host polymorphisms with the malaria parasite. Results can occur by chance, and previous studies have reported data from a single time point. No polymorphism showed both a reduction in parasite prevalence/density and age-specific seroconversion to anti-VSA antibodies. We interpret these findings to indicate that the mechanisms of protection by these polymorphisms are not fully explained by either structural aspects of the erythrocyte preventing infection or by enhanced immune responses to VSA. Our observations from PNG differ significantly from those we and others have seen for African children with HbAS and/or Hb C carriers. HbAS individuals have lower parasite prevalence/densities and delayed time to reinfection, as well as increased prevalence of anti-VSA antibodies, compared to those of normal genotype [18,24,36-39,44,82,83]. Whereas HbC carriers exhibit no differences in parasite density, yet higher immune responses to VSA [83]. The enhanced immune reactivity in Hb S and HbC carriers would suggest that protection against malaria is partially mediated by acquired immunity. Conversely, the polymorphisms investigated in PNG may confer protection against the clinical pathologies of P. falciparum infection by a mechanism that does not influence parasite density or immunity to VSA.
###end p 46
###begin title 47
Authors' contributions
###end title 47
###begin p 48
FJIF performed data analysis, interpreted data and prepared the final manuscript with KPD. PM helped to draft the manuscript and undertook laboratory work (FACS assay and PCR-based host genotyping except CR1). LP and CMW helped undertake laboratory work and interpret data. HI and LT undertook laboratory and field work. RR participated in the design of analysis. CSM, AJFL and KPD conceived the study, participated in its design, and obtained funding for the project. All authors discussed the results and approved the final manuscript.
###end p 48
###begin title 49
Acknowledgements
###end title 49
###begin p 50
We thank all the Amele volunteers for their participation in the study and the staff from the Papua New Guinea Institute of Medical Research in Madang for their assistance in collecting and processing blood samples and for malaria microscopy readings. This investigation received financial support from the Wellcome Trust (Programme grant No 041354) and the European Union INCO Programme (contract no. IC18-CT98-0359). The authors have no conflicts of interest.
###end p 50
###begin article-title 51
###xml 28 36 <span type="species:ncbi:9606">children</span>
alpha+-Thalassemia protects children against disease caused by other infections as well as malaria
###end article-title 51
###begin article-title 52
###xml 36 44 <span type="species:ncbi:9606">children</span>
alpha+-Thalassemia protects African children from severe malaria
###end article-title 52
###begin article-title 53
###xml 86 108 86 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum </italic>
###xml 86 107 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Both heterozygous and homozygous alpha+ thalassemias protect against severe and fatal Plasmodium falciparum malaria on the coast of Kenya
###end article-title 53
###begin article-title 54
###xml 86 94 <span type="species:ncbi:9606">children</span>
The effect of alpha(+)-thalassaemia on the incidence of malaria and other diseases in children living on the coast of Kenya
###end article-title 54
###begin article-title 55
###xml 56 78 56 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum </italic>
###xml 2 7 <span type="species:ncbi:9606">human</span>
###xml 56 77 <span type="species:ncbi:5833">Plasmodium falciparum</span>
A human complement receptor 1 polymorphism that reduces Plasmodium falciparum rosetting confers protection against severe malaria
###end article-title 55
###begin article-title 56
Natural selection of hemi- and heterozygotes for G6PD deficiency in Africa by resistance to severe malaria
###end article-title 56
###begin article-title 57
###xml 34 42 <span type="species:ncbi:9606">children</span>
Prevention of cerebral malaria in children in Papua New Guinea by southeast Asian ovalocytosis band 3
###end article-title 57
###begin article-title 58
Ovalocytosis and cerebral malaria [letter]
###end article-title 58
###begin article-title 59
Short report: severe malaria associated with blood group
###end article-title 59
###begin article-title 60
The role of red blood cell polymorphisms in resistance and susceptibility to malaria
###end article-title 60
###begin article-title 61
Negative epistasis between the malaria-protective effects of alpha(+)-thalassemia and the sickle cell trait
###end article-title 61
###begin article-title 62
X-Linked G6PD deficiency protects hemizygous males but not heterozygous females against severe malaria
###end article-title 62
###begin article-title 63
Hemoglobin C associated with protection from severe malaria in the Dogon of Mali, a West African population with a low prevalence of hemoglobin S
###end article-title 63
###begin article-title 64
###xml 58 66 <span type="species:ncbi:9606">children</span>
Hemoglobin C and resistance to severe malaria in Ghanaian children
###end article-title 64
###begin article-title 65
###xml 40 62 40 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum </italic>
###xml 40 61 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Haemoglobin C protects against clinical Plasmodium falciparum malaria
###end article-title 65
###begin article-title 66
Influence of hemoglobin E trait on the severity of Falciparum malaria
###end article-title 66
###begin article-title 67
###xml 91 104 91 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P falciparum </italic>
Hemoglobin E: a balanced polymorphism protective against high parasitemias and thus severe P falciparum malaria
###end article-title 67
###begin article-title 68
Protective effects of the sickle cell gene against malaria morbidity and mortality
###end article-title 68
###begin article-title 69
An Immune Basis for Malaria Protection by the Sickle Cell Trait
###end article-title 69
###begin article-title 70
###xml 34 56 34 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum </italic>
###xml 34 55 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Sickle Cell Trait and the Risk of Plasmodium falciparum Malaria and Other Childhood Diseases
###end article-title 70
###begin article-title 71
###xml 38 60 38 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum </italic>
###xml 38 59 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Blood group O protects against severe Plasmodium falciparum malaria through the mechanism of reduced rosetting
###end article-title 71
###begin article-title 72
Hemoglobin variants and disease manifestations in severe falciparum malaria
###end article-title 72
###begin article-title 73
Red blood cell defects and malaria
###end article-title 73
###begin article-title 74
Enhanced phagocytosis of ring-parasitized mutant erythrocytes. A common mechanism that may explain protection against falciparum-malaria in sickle-trait and beta-thalassemia-trait
###end article-title 74
###begin article-title 75
###xml 10 32 10 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum </italic>
###xml 10 31 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Growth of Plasmodium falciparum induces stage-dependent haemichrome formation, oxidative aggregation of band 3, membrane deposition of complement and antibodies, and phagocytosis of parasitized erythrocytes
###end article-title 75
###begin article-title 76
###xml 101 123 101 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum </italic>
###xml 101 122 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Early phagocytosis of glucose-6-phosphate dehydrogenase (G6PD)-deficient erythrocytes parasitized by Plasmodium falciparum may explain malaria protection in G6PD deficiency
###end article-title 76
###begin article-title 77
Brief communication: Resistance to Falciparum malaria in alpha-thalassemia, oxidative stress, and hemoglobin oxidation
###end article-title 77
###begin article-title 78
###xml 41 63 41 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum </italic>
###xml 41 62 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Protection by alpha-thalassaemia against Plasmodium falciparum malaria: modified surface antigen expression rather than impaired growth or cytoadherence
###end article-title 78
###begin article-title 79
Complement-regulatory proteins in severe malaria: too little or too much of a good thing?
###end article-title 79
###begin article-title 80
###xml 0 22 0 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum </italic>
###xml 0 21 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Plasmodium falciparum rosetting is associated with malaria severity in Kenya
###end article-title 80
###begin article-title 81
###xml 87 108 87 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum</italic>
###xml 87 108 <span type="species:ncbi:5833">Plasmodium falciparum</span>
The effects of hemoglobin genotype and ABO blood group on the formation of rosettes by Plasmodium falciparum-infected red blood cells
###end article-title 81
###begin article-title 82
###xml 34 56 34 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum </italic>
###xml 34 55 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Natural protection against severe Plasmodium falciparum malaria due to impaired rosette formation
###end article-title 82
###begin article-title 83
Protection afforded by sickle-cell trait against subtertian malareal infection
###end article-title 83
###begin article-title 84
Common west African HLA antigens are associated with protection from severe malaria
###end article-title 84
###begin article-title 85
###xml 117 139 117 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum </italic>
###xml 117 138 <span type="species:ncbi:5833">Plasmodium falciparum</span>
###xml 159 167 <span type="species:ncbi:9606">children</span>
A prospective study of the influence of alpha thalassaemia on morbidity from malaria and immune responses to defined Plasmodium falciparum antigens in Gambian children
###end article-title 85
###begin article-title 86
###xml 21 43 21 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum </italic>
###xml 21 42 <span type="species:ncbi:5833">Plasmodium falciparum</span>
###xml 56 64 <span type="species:ncbi:9606">patients</span>
Higher resistance to Plasmodium falciparum infection in patients with homozygous sickle cell disease in western Kenya
###end article-title 86
###begin article-title 87
###xml 22 44 22 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum </italic>
###xml 22 43 <span type="species:ncbi:5833">Plasmodium falciparum</span>
###xml 78 85 <span type="species:ncbi:9606">infants</span>
Longitudinal study of Plasmodium falciparum infection and immune responses in infants with or without the sickle cell trait
###end article-title 87
###begin article-title 88
###xml 38 60 38 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum </italic>
###xml 38 59 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Antibodies to blood stage antigens of Plasmodium falciparum in rural Gambians and their relation to protection against infection
###end article-title 88
###begin article-title 89
###xml 52 74 52 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum </italic>
###xml 52 73 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Host factors affecting the delay of reappearance of Plasmodium falciparum after radical treatment among a semi-immune population exposed to intense perennial transmission
###end article-title 89
###begin article-title 90
A comparison of case-control and family-based association methods: the example of sickle-cell and malaria
###end article-title 90
###begin article-title 91
###xml 22 44 22 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum </italic>
###xml 22 43 <span type="species:ncbi:5833">Plasmodium falciparum</span>
###xml 67 75 <span type="species:ncbi:9606">children</span>
Uncommon asymptomatic Plasmodium falciparum infections in Gabonese children
###end article-title 91
###begin article-title 92
Abnormal haemoglobins in the Sudan savanna of Nigeria. I. Prevalence of haemoglobins and relationships between sickle cell trait, malaria and survival
###end article-title 92
###begin article-title 93
###xml 19 41 19 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum </italic>
###xml 19 40 <span type="species:ncbi:5833">Plasmodium falciparum</span>
###xml 54 62 <span type="species:ncbi:9606">children</span>
Protection against Plasmodium falciparum infection in children with hemoglobin S
###end article-title 93
###begin article-title 94
###xml 55 77 55 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum </italic>
###xml 55 76 <span type="species:ncbi:5833">Plasmodium falciparum</span>
###xml 89 97 <span type="species:ncbi:9606">children</span>
Morbidity from malaria and immune responses to defined Plasmodium falciparum antigens in children with sickle cell trait in The Gambia
###end article-title 94
###begin article-title 95
Alpha thalassaemia in Papua New Guinea
###end article-title 95
###begin article-title 96
###xml 44 66 44 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum </italic>
###xml 44 65 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Associations between alpha+-thalassemia and Plasmodium falciparum malarial infection in northeastern Tanzania
###end article-title 96
###begin article-title 97
Hereditary ovalocytosis and reduced susceptibility to malaria in Papua New Guinea
###end article-title 97
###begin article-title 98
Ovalocytosis protects against severe malaria parasitemia in the Malayan aborigines
###end article-title 98
###begin article-title 99
###xml 51 72 51 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum</italic>
###xml 51 72 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Factors influencing resistance to reinfection with Plasmodium falciparum
###end article-title 99
###begin article-title 100
###xml 62 84 62 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum </italic>
###xml 48 56 <span type="species:ncbi:9606">patients</span>
###xml 62 83 <span type="species:ncbi:5833">Plasmodium falciparum</span>
[Erythrocyte defects and parasitemia density in patients with Plasmodium falciparum malaria in Buenaventura, Colombia]
###end article-title 100
###begin article-title 101
###xml 59 67 <span type="species:ncbi:9606">children</span>
Host polymorphisms and the incidence of malaria in Ugandan children
###end article-title 101
###begin article-title 102
###xml 45 67 45 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum </italic>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 45 66 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Human genetic polymorphisms and asymptomatic Plasmodium falciparum malaria in Gabonese schoolchildren
###end article-title 102
###begin article-title 103
Genetic red cell disorders and severity of falciparum malaria in Myanmar
###end article-title 103
###begin article-title 104
Haptoglobin levels are associated with haptoglobin genotype and {alpha}+-thalassemia in a malaria-endemic area
###end article-title 104
###begin article-title 105
Blood groups and malaria
###end article-title 105
###begin article-title 106
Glucose-6-phosphate dehydrogenase deficiency and Southeast Asian ovalocytosis in asymptomatic Plasmodium carriers in Sumba island, Indonesia
###end article-title 106
###begin article-title 107
Glycophorin C (Gerbich antigen blood group) and band 3 polymorphisms in two malaria holoendemic regions of Papua New Guinea
###end article-title 107
###begin article-title 108
ABO blood groups and falciparum malaria
###end article-title 108
###begin article-title 109
###xml 46 54 <span type="species:ncbi:9606">children</span>
Frequency of blood group antigens in Nigerian children with falciparum malaria
###end article-title 109
###begin article-title 110
The contribution of alpha+-thalassaemia to anaemia in a Nigerian population exposed to intense malaria transmission
###end article-title 110
###begin article-title 111
The interaction of alpha thalassaemia with malaria
###end article-title 111
###begin article-title 112
###xml 48 56 <span type="species:ncbi:9606">children</span>
High incidence of malaria in alpha-thalassaemic children
###end article-title 112
###begin article-title 113
###xml 0 22 0 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum </italic>
###xml 0 21 <span type="species:ncbi:5833">Plasmodium falciparum</span>
###xml 34 39 <span type="species:ncbi:9606">human</span>
###xml 86 94 <span type="species:ncbi:9606">children</span>
Plasmodium falciparum malaria and human red cells. I. A genetic and clinical study in children
###end article-title 113
###begin article-title 114
###xml 43 51 <span type="species:ncbi:9606">children</span>
Red cell morphology and malaria anaemia in children with Southeast-Asian ovalocytosis band 3 in Papua New Guinea
###end article-title 114
###begin article-title 115
Association of haptoglobin levels with age, parasite density, and haptoglobin genotype in a malaria-endemic area of Gabon
###end article-title 115
###begin article-title 116
New insights into the epidemiology of malaria relevant for disease control
###end article-title 116
###begin article-title 117
###xml 0 21 0 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum</italic>
###xml 0 21 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Plasmodium falciparum: analysis of the antibody specificity to the surface of the trophozoite-infected erythrocyte
###end article-title 117
###begin article-title 118
###xml 101 123 101 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum </italic>
###xml 101 122 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Insecticide-treated bed nets reduce plasma antibody levels and limit the repertoire of antibodies to Plasmodium falciparum variant surface antigens
###end article-title 118
###begin article-title 119
###xml 53 74 53 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum</italic>
###xml 53 74 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Antigenic diversity and the transmission dynamics of Plasmodium falciparum
###end article-title 119
###begin article-title 120
The epidemiology of malaria in a population surrounding Madang, Papua New Guinea
###end article-title 120
###begin article-title 121
Deletion in erythrocyte band 3 gene in malaria-resistant Southeast Asian ovalocytosis
###end article-title 121
###begin article-title 122
Whole genome amplification from a single cell: implications for genetic analysis
###end article-title 122
###begin article-title 123
###xml 68 76 <span type="species:ncbi:9606">children</span>
Dynamics of malaria parasitaemia associated with febrile illness in children from a rural area of Madang, Papua New Guinea
###end article-title 123
###begin article-title 124
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human malaria parasites in continuous culture
###end article-title 124
###begin article-title 125
###xml 82 104 82 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum </italic>
###xml 82 103 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Genes necessary for expression of a virulence determinant and for transmission of Plasmodium falciparum are located on a 0.3-megabase region of chromosome 9
###end article-title 125
###begin article-title 126
###xml 52 74 52 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum </italic>
###xml 52 73 <span type="species:ncbi:5833">Plasmodium falciparum</span>
###xml 79 84 <span type="species:ncbi:9606">human</span>
Separation of viable schizont-infected red cells of Plasmodium falciparum from human blood
###end article-title 126
###begin article-title 127
Hematologically important mutations: glucose-6-phosphate dehydrogenase
###end article-title 127
###begin article-title 128
Protection against clinical malaria by heterologous immunoglobulin G antibodies against malaria-infected erythrocyte variant surface antigens requires interaction with asymptomatic infections
###end article-title 128
###begin article-title 129
###xml 72 94 72 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum </italic>
###xml 72 93 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Short report: Positive correlation between rosetting and parasitemia in Plasmodium falciparum clinical isolates
###end article-title 129
###begin article-title 130
###xml 89 111 89 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum </italic>
###xml 89 110 <span type="species:ncbi:5833">Plasmodium falciparum</span>
The sickle cell trait is associated with enhanced immunoglobulin G antibody responses to Plasmodium falciparum variant surface antigens
###end article-title 130
###begin article-title 131
###xml 54 76 54 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum </italic>
###xml 54 75 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Haemoglobin C and S Role in Acquired Immunity against Plasmodium falciparum Malaria
###end article-title 131

